These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4757144)

  • 41. Effect of certain tablet formulation factors on the antimicrobial activity of tetracycline hydrochloride and chloramphenicol. 2. Effect of disintegrants.
    Asker A; el-Nakeeb M; Motawi M; el-Gindy N
    Pharmazie; 1973 Jul; 28(7):474-6. PubMed ID: 4767500
    [No Abstract]   [Full Text] [Related]  

  • 42. [The binding capacity of serum proteins for cardanolides and the influence of calcium].
    Pfordte K; Förster W
    Acta Biol Med Ger; 1970; 25(1):19-28. PubMed ID: 5489677
    [No Abstract]   [Full Text] [Related]  

  • 43. Design of the optimal topical system for fluocinonide.
    Reinstein J; Ostrenga J; Haleblian J; Shastri S; Poulsen B; Katz M
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):Suppl 67:13-8. PubMed ID: 5291642
    [No Abstract]   [Full Text] [Related]  

  • 44. [Biopharmacy].
    Modrzejewski F
    Pharmazie; 1971 Nov; 26(11):661. PubMed ID: 5154318
    [No Abstract]   [Full Text] [Related]  

  • 45. [Drug combination. Problems of technologic nature].
    Bagnarese P; Guadagnini G; Rugginenti GC
    Boll Chim Farm; 1971 Mar; 110(3):161-9. PubMed ID: 5561777
    [No Abstract]   [Full Text] [Related]  

  • 46. The formulation of aspirin.
    Martin BK
    Adv Pharm Sci; 1971; 3():107-71. PubMed ID: 4947388
    [No Abstract]   [Full Text] [Related]  

  • 47. [Biopharmacy and pharmacokinetics].
    Janků I
    Pharmazie; 1971 Nov; 26(11):660. PubMed ID: 5154317
    [No Abstract]   [Full Text] [Related]  

  • 48. [Possibilities and propositions of teaching biopharmacy in education of pharmacists].
    Kedvessy G
    Pharmazie; 1971 Nov; 26(11):655-6. PubMed ID: 5154314
    [No Abstract]   [Full Text] [Related]  

  • 49. Assessment of the feasibility of oral controlled release in an exploratory development setting.
    Thombre AG
    Drug Discov Today; 2005 Sep; 10(17):1159-66. PubMed ID: 16182208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nanocarriers.
    Torchilin VP
    Pharm Res; 2007 Dec; 24(12):2333-4. PubMed ID: 17934800
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Drug dosage form and action].
    Zathurecký L
    Med Klin; 1974 Apr; 69(16):667-70. PubMed ID: 4837397
    [No Abstract]   [Full Text] [Related]  

  • 52. [Digoxin--"the preparation has become more potent"].
    Redfors A
    Lakartidningen; 1973 Feb; 70(6):471-2. PubMed ID: 4683686
    [No Abstract]   [Full Text] [Related]  

  • 53. [Significance and problems of biopharmacy].
    Mielck JB; Speiser PP
    Pharmazie; 1971 Nov; 26(11):652-5. PubMed ID: 5154313
    [No Abstract]   [Full Text] [Related]  

  • 54. [Various thoughts on biopharmacy and pharmacokinetics of today].
    Zathurecký L
    Pharmazie; 1971 Nov; 26(11):650-2. PubMed ID: 5154312
    [No Abstract]   [Full Text] [Related]  

  • 55. Roll compaction/dry granulation: pharmaceutical applications.
    Kleinebudde P
    Eur J Pharm Biopharm; 2004 Sep; 58(2):317-26. PubMed ID: 15296958
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical problems associated with the variable biologic availability of digoxin.
    Shaw TR
    Am Heart J; 1974 Mar; 87(3):399-401. PubMed ID: 4812378
    [No Abstract]   [Full Text] [Related]  

  • 57. [Contribution of biopharmacy to pharmaceutical research. Development from pharmacokinetic theories].
    Bieder A; Gaillot J
    Farmaco Prat; 1972 Sep; 27(9):471-500. PubMed ID: 5074779
    [No Abstract]   [Full Text] [Related]  

  • 58. Biopharmacy and Pharmaceutical Technology Meeting. Oss, The Netherlands, 14 May 1993. Abstracts.
    Pharm World Sci; 1993 Apr; 15(2 Suppl C):C1-6. PubMed ID: 8485506
    [No Abstract]   [Full Text] [Related]  

  • 59. Bioavailability od digoxin.
    Fraser EJ; Leach RH; Poston JW
    Lancet; 1972 Sep; 2(7776):541. PubMed ID: 4115595
    [No Abstract]   [Full Text] [Related]  

  • 60. Biopharmacy and Pharmaceutical Technology Meeting. Leiderdorp, The Netherlands, 9 June 1995. Abstracts.
    Pharm World Sci; 1995 May; 17(3 Suppl H):H3-7. PubMed ID: 7606229
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.